InChI=1S/C26H32O2/c1-19-11-13-23(14-12-19)22(10-6-8-20(2)18-25(27)28)15-16-24-21(3)9-7-17-26(24,4)5/h6,8,10-16,18H,7,9,17H2,1-5H3,(H,27,28)/b8-6+,16-15+,20-18+,22-10- |
RQANARBNMTXCDM-DKOHIBGUSA-N |
C\C(\C=C\C=C(\C=C\C1=C(C)CCCC1(C)C)/C1=CC=C(C)C=C1)=C/C(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
AP-1 antagonist
An antogonist that interferes with the action of activator protein 1 (AP-1).
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(2E,4E,6Z,8E)-3-methyl-7-(4-methylphenyl)-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
|
(2E,4E,6Z,8E)-3-methyl-7-(p-tolyl)-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
|
ChEBI
|
(E,E,Z,E)-3-methyl-7-(4-methylphenyl)-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
|
SUBMITTER
|
SR 11302
|
SUBMITTER
|
SR-11303
|
ChEBI
|
160162-42-5
|
CAS Registry Number
|
SUBMITTER
|
21515313
|
PubMed citation
|
Europe PMC
|
23760290
|
PubMed citation
|
Europe PMC
|
24587316
|
PubMed citation
|
Europe PMC
|
24831826
|
PubMed citation
|
Europe PMC
|
25001622
|
PubMed citation
|
Europe PMC
|
26908177
|
PubMed citation
|
Europe PMC
|
27490694
|
PubMed citation
|
Europe PMC
|
29177791
|
PubMed citation
|
Europe PMC
|
31392841
|
PubMed citation
|
Europe PMC
|
33119185
|
PubMed citation
|
Europe PMC
|
33794365
|
PubMed citation
|
Europe PMC
|
35559742
|
PubMed citation
|
Europe PMC
|
35966011
|
PubMed citation
|
Europe PMC
|
36035373
|
PubMed citation
|
Europe PMC
|
36670963
|
PubMed citation
|
Europe PMC
|
36898276
|
PubMed citation
|
Europe PMC
|
37707834
|
PubMed citation
|
Europe PMC
|
9159159
|
PubMed citation
|
Europe PMC
|
|